JPRN-jRCT2080221890招募中1 期
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •1.Presents gradual and progressive change in memory function reported by participant or partner over more than 6 months
- •2.Meets criteria for MCI due to AD or Mild AD based on Free and Cued Selective Reminding score with Immediate Recall (FCSRT-IR) of greater than or equal to 16 for free recall or greater than or equal to 40 for total recall
- •3.Clinical Dementia Rating Scale (CDR) score of 0.5 or 1, memory box score of less than or equal to 0.5
- •4.Mini Mental State Examination (MMSE) score of 20-30
- •5.florbetapir F18 scan positive for the presence of amyloid beta
- •6.Women must be postmenopausal
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer'sDisease or Mild Alzheimer's DiseaseEUCTR2011-005217-37-ITELI LILLY AND COMPANY260
进行中（未招募）
不适用
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer's DiseaseMedDRA version: 14.1Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 100000004852EUCTR2011-005217-37-NLEli Lilly and Company260
已完成
2 期
Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients with Mild Cognitive Impairment Due to Alzheimer*s Disease or Mild Alzheimer's Disease10057167DementiaAlzheimer's DiseaseNL-OMON39447Eli Lilly20
进行中（未招募）
不适用
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer?s Disease or Mild Alzheimer's DiseaseMedDRA version: 15.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2011-005217-37-ESEli Lilly and Company260
已完成
不适用
Pharmacokinetics and safety of DA-6034KCT0000793Dong-A Pharm67